Eckel Clemens, Sötemann Dagmar, Kim Won-Keun, Grothusen Christina, Tiyerili Vedat, Dohmen Guido, Renker Matthias, Charitos Efstratios, Hamm Christian W, Choi Yeong-Hoon, Möllmann Helge, Blumenstein Johannes
Department of Cardiology, St. Johannes Hospital, 44137 Dortmund, Germany.
Department of Cardiology, University of Oldenburg, 26129 Oldenburg, Germany.
J Clin Med. 2022 Sep 9;11(18):5313. doi: 10.3390/jcm11185313.
Self-expanding transcatheter valves (THV) seem superior to balloon-expanding valves in regard to the incidence of prosthesis-patient mismatch (PPM). Data on the occurrence of PPM with the ACURATE system as a representative of self-expanding prostheses in very small annuli, even below the applicable instructions for use (IFU), are scarce.
Data from 654 patients with severe native aortic stenosis treated with the smallest size ACURATE valve (size S, 23 mm) at two German high-volume centers from 06/2012 to 12/2021 were evaluated. We compared clinical and hemodynamic outcomes among patients with implantation in adherence to the recommended sizing (on-label = 529) and below the recommended sizing range (off-label = 125) and identified predictors for PPM in the overall population. BMI-adjusted PPM was defined according to VARC-3 recommendations.
Post-procedure, the mean gradient (10.0 mmHg vs. 9.0 mmHg, = 0.834) and the rate of paravalvular leakage (PVL) ≥ moderate (3.2% vs. 2.8%, = 0.770) were similar between on-label and off-label implantations. The rate of moderate to severe PPM (24%) was comparably low in ACURATE S, with a very low proportion of severe PPM whether implanted off- or on-label (4.9% vs. 3.8%, = 0.552). Thirty-day all-cause mortality was higher among patients with off-label implantations (6.5% vs. 2.3%, = 0.036). In the subgroup of these patients, no device-related deaths occurred, and cardiac causes did not differ (each 5). Besides small annulus area and high BMI, a multivariate analysis identified a greater cover index (OR 3.26), deep implantation (OR 2.25) and severe calcification (OR 2.07) as independent predictors of PPM.
The ACURATE S subgroup shows a convincing hemodynamic outcome according to low mean gradient even outside the previous IFUs without a relevant increase in the rate of PVL or PPM. In addition to known factors such as annulus area and BMI, potential predictors for PPM are severe annulus calcification and implantation depth. Nevertheless, the ACURATE system seems to be a reliable option in patients with very small annuli.
在人工瓣膜-患者不匹配(PPM)发生率方面,自膨胀经导管瓣膜(THV)似乎优于球囊扩张瓣膜。关于以ACURATE系统作为自膨胀假体代表在非常小的瓣环中(甚至低于适用的使用说明[IFU])发生PPM的数据很少。
对2012年6月至2021年12月期间在德国两个高容量中心接受最小尺寸ACURATE瓣膜(尺寸S,23mm)治疗的654例严重原发性主动脉瓣狭窄患者的数据进行评估。我们比较了按照推荐尺寸植入(标签内=529例)和低于推荐尺寸范围(标签外=125例)的患者的临床和血流动力学结果,并确定了总体人群中PPM的预测因素。根据VARC-3建议定义体重指数调整后的PPM。
术后,标签内和标签外植入患者的平均压差(10.0mmHg对9.0mmHg,P=0.834)和中度及以上瓣周漏(PVL)发生率(3.2%对2.8%,P=0.770)相似。ACURATE S瓣膜中重度PPM发生率(24%)相对较低,无论标签外还是标签内植入,重度PPM比例都非常低(4.9%对3.8%,P=0.552)。标签外植入患者的30天全因死亡率较高(6.5%对2.3%,P=0.036)。在这些患者亚组中,未发生与器械相关的死亡,心脏原因导致的死亡无差异(均为5例)。多因素分析确定,除瓣环面积小和体重指数高外,更大的覆盖指数(OR 3.26)、深部植入(OR 2.25)和重度钙化(OR 2.07)是PPM的独立预测因素。
ACURATE S亚组显示出令人信服的血流动力学结果,即使超出先前的IFU,平均压差仍较低,且PVL或PPM发生率无相关增加。除了瓣环面积和体重指数等已知因素外,PPM的潜在预测因素是重度瓣环钙化和植入深度。尽管如此,ACURATE系统似乎是瓣环非常小的患者的可靠选择。